Daily Stock Analysis, CHMA, Chiasma Inc, priceseries

Chiasma Inc. Daily Stock Analysis
Stock Information
Open
1.45
Close
1.50
High
1.50
Low
1.45
Previous Close
1.50
Daily Price Gain
0.00
YTD High
2.30
YTD High Date
Jan 6, 2017
YTD Low
1.45
YTD Low Date
May 26, 2017
YTD Price Change
-0.50
YTD Gain
-25.00%
52 Week High
3.71
52 Week High Date
Oct 5, 2016
52 Week Low
1.45
52 Week Low Date
May 26, 2017
52 Week Price Change
-1.60
52 Week Gain
-51.61%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 29. 2016
10.30
Feb 1. 2016
11.00
1 Trading Days
6.75%
Link
LONG
Feb 3. 2016
10.38
Feb 5. 2016
11.05
2 Trading Days
6.41%
Link
Company Information
Stock Symbol
CHMA
Exchange
NasdaqGS
Company URL
http://www.chiasmapharma.com
Company Phone
914-234-2268
CEO
Mark W. Leuchtenberger
Headquarters
Massachusetts
Business Address
831 BEACON STREET, SUITE 313, NEWTON CENTRE, MA 02459
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001339469
About

Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases.

Description

Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massachusetts.